300
Participants
Start Date
April 15, 2024
Primary Completion Date
June 1, 2025
Study Completion Date
September 1, 2025
Sivelestat sodium
Sevilastat sodium 4.8 mg/kg/d IV continuous infusion for 14 days or ICU length of stay (within 14 days)
Dexamethasone
Dexamethasone 10 mg IV once a day for 5 days or until extubation (within 5 days)
Sivelestat sodium placebo
Sivelestat sodium placebo 4.8 mg/kg/d IV continuous infusion for 14 days or ICU length of stay (within 14 days)
Dexamethasone placebo
Dexamethasone placebo 10 mg IV once a day for 5 days or until extubation (within 5 days)
RECRUITING
Peking Union Medical College Hospital, Beijing
NOT_YET_RECRUITING
Luoyang Central Hospital, Luoyang
RECRUITING
Yanan University Affiliated Hospital, Yan’an
NOT_YET_RECRUITING
The Third Hospital of Mianyang, Mianyang
Peking University
OTHER
Shanghai Huilun Pharmaceutical Co., Ltd.
INDUSTRY
Peking Union Medical College Hospital
OTHER